#137 - Paul Offit, M.D.: An expert perspective on COVID-19 vaccines

The Peter Attia Drive

Peter Attia, MD

Health & Fitness, Medicine, Fitness

4.7 • 7.3K Ratings

🗓️ 16 November 2020

⏱️ 96 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Paul Offit is a pediatrician specializing in infectious diseases and an expert in virology and vaccine development. He currently serves on the FDA committee overseeing and evaluating COVID-19 vaccines. In this episode, Paul discusses the strategies and major companies pursuing a vaccine against the SARS-CoV-2 virus. He gets into the nuances of the vaccine approval process and its implications for COVID-19 vaccine outlook. Paul also explains potential risks, reveals his own confidence level in safety, and gives insight into protection against reinfection with vaccination. Please note that this episode was recorded 11/05/2020, prior to the 11/09/2020 news release of the Pfizer vaccine update.

We discuss:

How Paul’s experience as a child in a chronic care hospital as child informed his path in pediatrics and vaccine development (3:30);
Addressing the anti-vaccination sentiment and explaining the fraudulent origins of the anti-vaccination movement (8:00);
Lessons and insights from 26 years studying rotavirus and creating a successful rotavirus vaccine (17:00);
Developing a new vaccine: the different phases of clinical trials, overall timeline, and financial costs (27:15);
Operation Warp Speed: the expedited process of creating a coronavirus vaccine (32:30);
Various vaccine strategies—RNA, DNA, virus vector—and the challenges associated (35:00);
The Moderna and Pfizer mRNA vaccines: strategy, timeline, and Emergency Use Authorization (41:15);
Paul’s confidence level in the safety of the first coronavirus vaccines (48:30);
The risks associated with different types of vaccines, and updates on the Johnson & Johnson and Astrazeneca coronavirus vaccines (52:15);
What we know about the coronavirus vaccines approved in Russia and China (55:45);
The latest on the Merck coronavirus vaccine (57:15);
The recombinant/purified protein vaccine approach for coronavirus—big players, risks, and the best vaccine for the elderly (57:45);
Attenuated and inactivated vaccine strategies for coronavirus (1:02:00);
The genetic drift of SARS-CoV-2: Impacts for protection and vaccine development (1:02:30);
Paul’s take on the hypothesis that a previous coronavirus infection offers protection against the novel COVID-19 (1:06:45);
Addressing the concern that antibodies fade over time (1:09:15);
Blood type and protective against coronavirus (1:13:00);
Distribution: the challenge of prioritizing the limited doses of vaccines after approval (1:13:15);
Paul’s perspective on COVID-19 vaccine safety (1:16:15);
Considerations regarding vaccinating children for coronavirus and the role of a fever immune response (1:21:45);
Why vaccine development can be challenging and risks of current COVID-19 strategies (1:29:45); and
More.

Learn more: https://peterattiamd.com/

Show notes page for this episode: https://peterattiamd.com/pauloffit

Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe/

Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/

Connect with Peter on Facebook | Twitter | Instagram.

Transcript

Click on a timestamp to play from that location

0:00.0	Hey everyone, welcome to the Drive Podcast.
0:13.0	I'm your host, Peter Atia.
0:14.8	This podcast, my website, and my weekly newsletter, all focus on the goal of translating
0:18.7	the science of longevity into something accessible for everyone.
0:22.4	Our goal is to provide the best content in health and wellness, full stop, and we've assembled
0:27.0	a great team of analysts to make this happen.
0:29.4	If you enjoy this podcast, we've created a membership program that brings you far more
0:33.2	in-depth content if you want to take your knowledge of this space to the next level.
0:37.3	At the end of this episode, I'll explain what those benefits are, or if you want to learn
0:41.0	more now, head over to peteratiamd.com forward slash subscribe.
0:46.3	Now without further delay, here's today's episode.
0:49.0	I guess this week is Dr. Paul Offit.
0:53.5	Paul's a pediatrician specializing in infectious diseases, and he's an expert on vaccines, immunology,
0:58.9	and virology.
0:59.9	He's the director of the Vaccine Education Center, and a professor of pediatrics in the
1:04.5	division of infectious diseases at CHOP, the Children's Hospital of Philadelphia.
1:09.0	He's also a professor of vaccinology at the Prolimin School of Medicine at the University
1:13.4	of Pennsylvania.
1:14.9	He's on the FDA Committee for Biologics Evaluation and Research Vaccines and Related Biological
1:20.2	Products Advisory Committee.
1:21.6	In other words, he's on the FDA Committee that is overseeing the basically unprecedented
1:27.7	scale with which vaccines are being put into a pipeline to be evaluated for COVID.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Peter Attia, MD, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Peter Attia, MD and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.